Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Change in Cash (2016 - 2025)

Historic Change in Cash for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to -$952807.0.

  • BioRestorative Therapies' Change in Cash fell 2490.87% to -$952807.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$887000.0, marking a year-over-year increase of 991.45%. This contributed to the annual value of -$336487.0 for FY2024, which is 5942.98% up from last year.
  • Per BioRestorative Therapies' latest filing, its Change in Cash stood at -$952807.0 for Q3 2025, which was down 2490.87% from $326462.0 recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' Change in Cash ranged from a high of $19.9 million in Q4 2021 and a low of -$11.4 million during Q3 2022
  • In the last 5 years, BioRestorative Therapies' Change in Cash had a median value of -$629364.0 in 2021 and averaged -$129587.7.
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 1819056.48% in 2021, then surged by 217327.68% in 2024.
  • BioRestorative Therapies' Change in Cash (Quarter) stood at $19.9 million in 2021, then tumbled by 124.42% to -$4.9 million in 2022, then skyrocketed by 67.29% to -$1.6 million in 2023, then surged by 40.77% to -$941554.0 in 2024, then decreased by 1.2% to -$952807.0 in 2025.
  • Its Change in Cash stands at -$952807.0 for Q3 2025, versus $326462.0 for Q2 2025 and $680899.0 for Q1 2025.